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Developing behavioural testing and MR imaging to 
evaluate cognitive impairment in models of CNS 
autoimmunity 
Background 
Multiple Sclerosis (MS) is the most common 
neurodegenerative disease in young adults in Canada. 
Although treatments are improving, there is currently no 
cure. Those living with MS will be affected by 
neurodegeneration for decades of their life - this will 
result in considerable economic cost and loss of quality 
of life for both those with MS and their caregivers. 
 
Most attention has been paid to the physical disability 
that develops over time, but there are also impacts on 
higher brain function. Cognitive impairment is found in 
40-65% of MS patients, impacting attention and working 
memory. Patients often experience cognitive fatigue, 
limiting their capacity to remain focused. These 
symptoms can appear very early in the disease, often at 
or within a year of initial diagnosis. Even before physical 
impairment becomes prohibitive, cognitive impairment 
can significantly impact work and family life. 
 
The Problem 
The best evidence suggests that neurodegeneration in 
MS is driven by an autoimmune response affecting the 
central nervous system (CNS). However, it is not clear if 
neural function deficits and cognitive fatigue are the 
result of targeted autoimmune attacks, or if they are a 
bystander effect of local or systemic inflammation. 
Current research tools focus almost exclusively on the 
physical disability side of MS. 
 
There is an urgent need to develop research tools and measures of higher brain functions in this type 
of CNS autoimmune disease. Such research tools could help in both understanding underlying 
mechanisms of the disease as well as studies of potential therapies. We are developing a research 
program to apply fMRI imaging to understand and measure the underlying mechanisms of cognitive 
fatigue and other higher-function deficits in MS patients. 
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The Project 
This project will investigate cognition and cognitive fatigue in models of CNS autoimmunity. We will 
use automated touchscreens and fMRI to measure deficits in higher order brain functions. 
 
We have two critical milestones in this project: 
 
* to use touchscreen testing protocols to determine if mouse models demonstrate the same kinds of 
attention, working memory and cognitive fatigue deficits observed in MS, and 
 
* to use fMRI to measure higher-order defects in the autoimmune models and identify any changes 
present that might be associated with cognitive dysfunction and the findings from human studies. 
 
 
Western Researchers 
Steven Kerfoot 
Sarah Morrow 
Ravi Menon 
Flavio Beraldo  
 
© 2020 BrainsCAN Western University 
This Summary is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License 
 
 
